𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tp53 gene therapy: a key to modulating resistance to anticancer therapies?

✍ Scribed by Esther H Chang; Kathleen F Pirollo; Kerrie B Bouker

Book ID
114381882
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
172 KB
Volume
6
Category
Article
ISSN
1357-4310

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Drug-resistant human bladder-cancer cell
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells
✍ Toshiro Shirakawa; Ryohei Sasaki; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 373 KB

We investigated the therapeutic potential and molecular mechanism of adenovirus-mediated wt p53 gene therapy for drug-resistant human bladder cancers. KK47, a human bladder-cancer cell line, along with the drug-resistant sublines KK47/DDP10, KK47/DDP20 (cisplatin-resistant) and KK47/ ADM (doxorubici

Duplication or amplification of chromoso
Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents
✍ Mette K. Andersen; Debes H. Christiansen; Maria Kirchhoff; Jens Pedersen-Bjergaa πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 266 KB πŸ‘ 1 views

## Abstract Gene amplification is a rare phenomenon in acute leukemia, but recently amplification of specific chromosome bands containing genes rearranged in leukemia‐specific balanced chromosome translocations has been reported in a few cases. We detected duplication or amplification of chromosome